Emcure Pharmaceuticals Company Description

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

It offers products in various therapeutic areas, such gynaecology, cardiovascular, blood-related, pain and analgesics, oncology/anti-neoplastics, anti-infectives, vitamins, minerals and nutrients, respiratory, HIV antivirals, Metabolics, gastro, anti-diabetic, neuro, derma, and mRNA vaccine.

It provides its products under Orofer-Xt, Zostum, Bevon, Amaryl M, Orofer Fcm, Maxtra, Clexane, Metpure-Xl, Amaryl, Spegra, Feronia-Xt, Cardace, Pause, Lornit, Targocid, Orofer-S, Lasilactone, Gros, Orofer-Xt Liq, And Tenectase brand names.

Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss.

Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Emcure Pharmaceuticals Limited

Country	India
Founded	1981
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	6,914
CEO	Satish Mehta

Contact Details

Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India
Phone	91 20 3507 0033
Website	emcure.com

Stock Details

Ticker Symbol	EMCURE
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE168P01015
SIC Code	2834

Key Executives

Name	Position
Tajuddin Sabir Shaikh	Chief Financial Officer
Amruta Jana Yangalwar	Company Secretary and Compliance Officer
Naveen Soni	Director of Corporate Communications and Public Relations
Vikas Madan Thapar	President of Corporate Development, Strategy and Finance
Rajesh Nair	President of Human Resources
Sanjay Rajanikant Mehta	President of Emerging Markets
Deepak Gondaliya	President of Technical Operations
R.S. Vasan	President of India Business
Brijendra Singh	Executive Vice-President
Piyush Nahar	Executive Vice President of Corporate Strategy and Development